Financials and Estimates

Financials and Estimates

Figures converted from RMB at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

Meituan's three-year record splits cleanly in two: FY2022–FY2024 is a company scaling into rising profitability and heavy cash generation; FY2025 is a single year in which a subsidy war turned a record $4.6 billion profit into a $3.0 billion loss and a $7.4 billion operating cash inflow into a $1.8 billion outflow. Revenue never stopped growing. Consensus expects a return to profit by 2027, but the balance sheet — not the income statement — is what makes the wait survivable.

The three-year record

Over FY2023–FY2025 revenue rose from $35.4 billion to $46.9 billion — a 13% annual pace even after 2025's disruption — while the bottom line moved sharply: a $1.8 billion profit in 2023, a record $4.6 billion in 2024, then a $3.0 billion loss in 2025 [1].

Sources: FY2025 Annual Report, Financial Summary [2] and Liquidity and Capital Resources [3].

Source: FY2025 Annual Report, Financial Summary — five-year condensed statements [4].

The table below is the statutory record for the reader's stated three-year window. The story is in the last column: revenue up 8.1% in 2025, yet gross profit down $2.4 billion and the result swinging by $7.6 billion year-on-year.

Source: FY2025 Annual Report — Financial Summary [5] and Consolidated Income Statement [6].

Where the profit went

The loss was manufactured almost entirely by competition, and it hit through two lines at once. On the cost side, cost of revenue rose from 61.6% of sales in 2024 to 69.6% in 2025 — an 8-point compression of gross margin — as delivery and rider incentives inflated the cost of each order [7]. Below gross profit, selling and marketing expense jumped from $8.2 billion to $13.2 billion — from 19.0% to 28.2% of revenue — as Meituan matched the consumer and merchant subsidies that JD and Alibaba put into the market [8]. Research and development and general expenses barely moved.

Source: FY2025 Annual Report, Management Discussion and Analysis [9]; Consolidated Income Statement [10].

Put together, reported operating profit swung from $4.7 billion (a 10.9% margin) to a $3.2 billion loss — a roughly 18-point move, split about evenly between gross-margin compression in the cost of revenue and the marketing surge [11]. The mechanism matters for the through-line: a demand collapse would show up as falling revenue; this shows up as a deliberate, subsidy-funded fight for order share while revenue kept climbing. That is a discretionary loss, which is easier to reverse than a structural one — provided the spending actually stops. The unresolved question is how much of the 8-point gross-margin hit reverts when it does, which is a matter for the unit-economics case rather than the reported ledger.

One check guards against the loss being a statutory artifact. Meituan's own non-IFRS measures — which add back share-based compensation and similar items and usually flatter the result — tell the same story: adjusted net profit swung from $5.6 billion in 2024 to a $2.4 billion adjusted loss in 2025, and adjusted EBITDA from $6.3 billion to negative $1.8 billion [12]. The loss is real cash economics, not an accounting line.

Cash tells the same story

In the two profitable years, Meituan's earnings were high quality: operating cash flow ran well ahead of reported profit — $5.2 billion against $1.8 billion in 2023, $7.4 billion against $4.6 billion in 2024 — because the platform collects from users and merchants faster than it pays, and capital intensity is low (capex under 4% of revenue) [13]. That converted into $4.3 billion and $5.9 billion of free cash flow.

FY2025 reversed this. Operating cash flow was negative $1.8 billion and free cash flow negative $3.5 billion [14]. The subsidy war did not just dent an accounting margin; it drained roughly $3.5 billion of cash out the door in twelve months.

Source: FY2025 Annual Report, Liquidity and Capital Resources [15]; FY2024 Annual Report, Liquidity and Capital Resources [16].

The clearest sign of how management reads its own position: share buybacks, which absorbed $3.4 billion of cash in 2024, were cut to $47 million in 2025 [17]. Cash was being retained rather than returned — a capital-allocation shift explored more fully in the management chapter.

The balance sheet absorbed it

This is the part that speaks to a value investor's first concern, that a holding could go to zero. Meituan's balance sheet makes that outcome unlikely. At the end of 2025 Meituan held $13.7 billion of cash and a further $7.7 billion of short-term treasury investments, $21.4 billion in all, against total borrowings of about $10.3 billion — net cash of roughly $11.1 billion even after the worst operating year in its history [18].

Source: FY2025 Annual Report, Liquidity and Capital Resources [19]; prior-year cash and borrowings from reported financials, FY2022–FY2024.

The balance sheet stayed a fortress through the war only by leaning on debt: about $3.4 billion of net cash went out, replaced with $2.7 billion of fresh borrowing, while management widened the New Initiatives loss to $1.3 billion for an unproven overseas build and cut the buyback from $3.6 billion to $0.05 billion as the stock it had called undervalued fell below $10.20. The gross cash pile held roughly flat only because that $2.7 billion financing inflow came mainly from issuing notes payable and new borrowings, which is why total debt climbed from about $7.2 billion to $10.3 billion in the year [20]. Net cash fell by roughly $3.4 billion even as the headline cash balance rose. Against that, the gearing ratio is about 53%, some 55% of that debt matures in three years or more, and none of it carries a financial covenant [21]. A covenant-free, long-dated debt stack against $21 billion of liquid assets is why a full year of cash burn barely registered as a solvency question. On the reader's own bankruptcy-risk test, the evidence points to near-zero; the main thing that would change that read is a multi-year war, not a single one.

What the estimates expect

Consensus treats 2025 as the trough. Forty analysts put FY2026 revenue near $51.4 billion (up 10.3%) and thirty-six put FY2027 near $58.3 billion (up 13.6%) — growth returning to its pre-war double-digit pace. These are consensus estimates from the analyst data feed, not company guidance, and carry no filing page.

Source: reported revenue FY2023–FY2025 [22]; FY2026–FY2027 are consensus analyst estimates (40 and 36 contributors), as reported.

Source: consensus revenue and price-target estimates (current price $10.06; mean target $13.65), as reported.

The earnings turn is the softer part of the forecast. Consensus has EPS still modestly negative in FY2026 (about $0.07 loss per share on average, with a wide $0.23-loss-to-$0.10-profit range across contributors) before recovering to roughly $0.52 in FY2027 — a return to profit, though below the $0.73 diluted peak of 2024. The revisions run two ways: FY2026 estimates have been marked up over the past month (seventeen upgrades against three cuts) as the truce held, while FY2027 estimates have been trimmed (thirteen cuts) — near-term relief, out-year caution. Sell-side positioning is constructive despite the depressed tape: of 38 ratings, 28 are buy or strong-buy and only 2 are strong-sell, and the mean target of $13.65 sits about 36% above the $10.06 price. The price marks a fallen leader; sell-side coverage stays constructive.

The numbers here establish the base the rest of the report builds on. Whether 2025 was a dip or a reset is not settled by the ledger alone — the case is most sensitive to whether the 8-point gross-margin hit reverts as subsidies fade, and to whether the FY2027 profit consensus assumes survives contact with a competitor that has not formally surrendered. Both are questions for the chapters on unit economics and competition; the financials say only that Meituan can afford to wait for the answer.